Arrowhead Pharmaceuticals Inc (ARWR)

Net profit margin

		Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Net income	US$ in thousands	-599,493	-205,275	-176,063	-140,848	-84,553
Revenue	US$ in thousands	3,471	222,409	243,231	138,287	87,992
Net profit margin		-17,271.48%	-92.30%	-72.39%	-101.85%	-96.09%

September 30, 2024 calculation

Net profit margin = Net income ÷ Revenue
= $-599,493K ÷ $3,471K
= -17,271.48%

Arrowhead Pharmaceuticals Inc has seen fluctuations in its net profit margin over the past five years. In the most recent fiscal year, the net profit margin was -17,271.48%, a significant improvement compared to the previous years. However, it is important to note that negative net profit margins indicate that the company is operating at a loss.

In the fiscal year ending September 30, 2023, the net profit margin was -92.30%, followed by -72.39% in 2022, -101.85% in 2021, and -96.09% in 2020. These negative margins suggest that Arrowhead Pharmaceuticals Inc has been experiencing challenges in generating profits relative to its revenue.

Investors and stakeholders should monitor the company's efforts to improve its operational efficiency, control costs, and increase revenue in order to achieve positive net profit margins in the future. Further analysis of the company's overall financial performance and strategy may provide insights into the factors influencing its net profit margin.